New Pain Management Strategies Spelled Out
National initiatives are designed to provide education, advance research, solve the opioid crisis, and help patients.
Break From Methotrexate Boosts Flu Shot Efficacy in RA
With a drug holiday, patients with rheumatoid arthritis could improve their response to influenza vaccinations without increasing disease activity.
In RA, No Added Second Malignancy Risk With Biologics
Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.
How Cannabis Might Treat Rheumatic Diseases
The role of legalized marijuana in society and evidence-based medicine was examined at the ACR/ARHP Annual Meeting.
Biologic Use in Pregnancy Does Not Increase Infant Infection Risk
New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.
Fitness Interventions for Rheumatologic Fatigue and Pain
The ACR/ARHP Annual Meeting provided a research update on surrounding issues and strategies for helping patients.
Biosimilars: To Switch or Not to Switch?
The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting.
No Gold Standard Biomarker for Lupus Flare Prediction
A recent systematic review of literature found no validated and widely accepted biomarker.
First UK Guidelines for Adults with Lupus
Up-to-date guidelines were developed to help improve patient outcomes.
Rheumatoid Arthritis Risk Rises With Working in the Cold
Exposure to cold environments has been linked to disease development, and new findings may help prevention.